Folate receptor targeted nanoparticle drug conjugates and uses thereof

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11957760
APP PUB NO 20230263899A1
SERIAL NO

18183328

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure relates to nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates, and methods of making and using them to treat cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELUCIDA ONCOLOGY INC1 DEER PARK DRIVE SUITE E MONMOUTH JUNCTION NJ 08852

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Adams, Gregory Paul Hatboro, US 4 4
Chen, Feng Princeton, US 635 6497
Gardinier,, II Thomas Courtney Raritan, US 5 6
Germano,, Jr Geno J Philadelphia, US 5 6
Lee, Francis Y F Yardley, US 11 118
Ma, Kai Montgomery, US 133 7232
Türker, Melik Ziya Princeton, US 5 6
Venkatesan, Aranapakam M Rego Park, US 57 453
Wu, Fei Plainsboro, US 179 1254

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 16, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 16, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 16, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00